SCHEMBL7570544

SCHEMBL7570544

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(CO)OCC(O)CO

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.76
DGKA P23743 1/20 0.75
PRKCA P17252 2/20 0.68
PRKCE Q02156 1/20 0.68
PRKCQ Q04759 1/20 0.68
PRKCD Q05655 1/20 0.68
SELP P16109 1/20 0.68
CNR1 P21554 2/20 0.64
CNR2 P34972 2/20 0.64
KDM4E B2RXH2 1/20 0.61
DUSP3 P51452 1/20 0.61
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
LMNA P02545 1/20 0.61
ALDH1A1 P00352 1/20 0.58
MAPT P10636 1/20 0.58
HPGD P15428 1/20 0.58
S1PR1 P21453 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2550552 0.96 DGKA (0.81) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL9510703 0.94 DGKA (0.77) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL8781081 0.93 DGKA (0.82) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL14151288 0.93 DGKA (0.82) FAAHDGKAPRKCAPRKCEPRKCQ
SCHEMBL8577750 0.91 DGKA (0.72) FAAHDGKAPRKCAPRKCEPRKCQ
Glyceryl Monolinoleate SCHEMBL19564919 0.90 FAAH (0.92) FAAHDGKAPRKCAPRKCEPRKCQ
Glyceryl Monolinoleate SCHEMBL154133 0.90 FAAH (0.92) FAAHDGKAPRKCAPRKCEPRKCQ
Glyceryl Monolinoleate SCHEMBL4350267 0.90 FAAH (0.92) FAAHDGKAPRKCAPRKCEPRKCQ
Glyceryl Monolinoleate SCHEMBL8536841 0.90 FAAH (0.92) FAAHDGKAPRKCAPRKCEPRKCQ
Glyceryl Monolinoleate SCHEMBL29512923 0.90 FAAH (0.92) FAAHDGKAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020041854-A1 Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods L'OREAL S.A. (FR) 2002-04-11 US claimed
US-20020041854-A1 Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods L'OREAL S.A. (FR) 2002-04-11 US disclosed
US-20020034480-A1 Make-up compositions comprising a binder phase, and make-up methods L'OREAL, S.A. (FR) 2002-03-21 US disclosed
WO-1990015593-A1 A PROCESS FOR THE PREPARATION OF DRUG PARTICLES YTKEMISKA INSTITUTET (SE) 1990-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034480-A1 Make-up compositions comprising a binder phase, and make-up methods TTR, GRN, MB FAAH 4432/4885DGKA 2219/4885PRKCA 2041/4885
US-20020041854-A1 Cosmetic compositions in powder form comprising a binder, and make-up and cosmetic care methods CUTA, LAGE3, MITF FAAH 3697/4885DGKA 3071/4885PRKCA 1505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.